- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03499418
Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates (PRE-HIFREQ)
Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Term and Near-term Neonates - Observational Study
Transient Tachypnea of the Newborn (TTN) is one of the common causes of neonatal respiratory distress as a result of delayed clearance of fetal lung fluid.
Neonates with TTN usually require noninvasive respiratory support (e.g. nasal cannula, nasal CPAP) and may need supplemental oxygen therapy to maintain normal oxygen saturation levels. There have also been reports of "malignant TTN," in which affected children develop persistent pulmonary hypertension of the newborn (PPHN).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Respiratory failure after birth is still a severe problem. Risk factors include premature labor and delivery by cesarean section. Despite the improvement of the quality of perinatal care in Poland, almost a constant percentage of premature babies has been born in Poland. The number of births by cesarean section is also rising - both planned and preceded by the attempt to vaginal delivery. TTN - Transient Tachypnea of the Newborn is one of the most common causes of respiratory failure in newborns. TTN occurs in approximately 10% of newborns born between 33 and 34 weeks of gestation, in about 5% of newborns born between 35 and 36 weeks and less than 1% of neonates.
At baseline of transient tachypnea of the newborn (TTN), there are disorders of absorption of pulmonary fluid. In the flow of water, epithelial sodium channels and Na+ / K+ -ATPase play an essential role. Their stimulation increases the absorption of water from the lung airspace and increases its transport both inside and outside the cell. In the subsequent stages of removal of interstitial pulmonary fluid, the vascular system and the lymphatic system are involved.
TTN is usually a self-limiting process, and treatments are not defined. There are also reports of "malignant TTN" in which infants develop persistent pulmonary hypertension of newborns (PPHN) (3). TTN infants typically require non-invasive respiratory support (CPAP, for example) and may need higher oxygen concentrations in the respiratory mixture to maintain proper oxygenation. Some experts suggest that the early use of expanding pressure (nasal CPAP) may relieve severe forms of TTN and prevent using of mechanical ventilation, and also may eventually prevent the development of persistent pulmonary hypertension.
Persistent pulmonary hypertension of newborns (PPHN) is a disorder arising at the stage of a physiological passage of fetal circulation into the neonatal circulation in the perinatal period. It is associated with a lack of decreasing pulmonary vascular resistance, which is influenced by increasing levels of oxygen in the blood and numerous biochemical and hormonal factors. From own observations and data from the literature, it is estimated that PPHN occurs in approximately 0.1-0.2% of newborns born term or near the term. Treatment of persistent pulmonary hypertension is difficult. Despite the use of mechanical ventilation, inhaled nitric oxide (iNO) or extracorporeal oxygenation (ECMO), the risk of death is still around 10-15%. This percentage has declined in recent years, but it is believed that persistent pulmonary hypertension of newborns is one of the most challenging situations in intensive care of newborns. In addition, infants who have undergone PPHN are exposed to long-term effects in the form of neurological complications or neurodevelopmental disorders.
Before initiating a clinical trial (intervention) with the experimental therapy, an initial follow-up study was conducted to assess the incidence of failure in respiratory insufficiency and the rate of PPHN in neonates born between 32 and 41 weeks of gestation. The failure of treatment will be defined as the need for invasive ventilation (intubation and mechanical ventilation). To accurately determine the degree of respiratory failure, a scale was developed that was an adaptation of the Silverman scale. PPHN will be defined by parameters measured in echocardiography and on changes in blood gases. Also, a comparison of parameters of acid-base balance and the type of treatment of respiratory failure after birth will be performed in the follow-up study. Based on the collected data, validation of the modified Silverman scale and evaluation of its clinical utility will be presented.
Study Type
Contacts and Locations
Study Locations
-
-
-
Warsaw, Poland, 00-315
- Department of Neonatology and Neonatal Intensive Care Medical University of Warsaw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- A signed form of informed consent from parents (legal guardians).
- 32 0/7 to 41 6/7 weeks of gestation
- The need to support postnatal breathing, no later than 6 hours of life.
Exclusion Criteria:
- The need for intubation in the after-birth procedures
- Age above 6 hours of age from birth
- Congenital heart defects
- Congenital diaphragmatic hernia
- Other severe congenital malformations and genetically determined syndromes, diagnosed before and after birth, associated with higher risk of respiratory failure.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
newborns with TTN
Group of late preterm and full-term newborns with TTN evaluated by modified Silverman scale
|
Clinical assessment of severity of respiratory failure
|
newborns with PPHN
Group of late preterm and full-term newborns with respiratory failure with PPHN evaluated by echocardiography
|
Clinical assessment of severity of respiratory failure
echocardiographic evaluation of haemodynamic problems
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of PPHN
Time Frame: 12 months
|
The primary endpoint for this study is time of respiratory failure (need to intubation) and incidence rate of PPHN
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The evaluation of the "TTN scale"
Time Frame: 12 months
|
The evaluation of the "TTN scale" in comparison to physiologic parameters:
|
12 months
|
Collaborators and Investigators
Investigators
- Study Chair: Maria K. Borszewska-Kornacka, MD, ProfTit, Medical University of Warsaw
Publications and helpful links
General Publications
- Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006 Sep;118(3):1207-14. doi: 10.1542/peds.2006-0018.
- Rubaltelli FF, Dani C, Reali MF, Bertini G, Wiechmann L, Tangucci M, Spagnolo A. Acute neonatal respiratory distress in Italy: a one-year prospective study. Italian Group of Neonatal Pneumology. Acta Paediatr. 1998 Dec;87(12):1261-8. doi: 10.1080/080352598750030951.
- Lakshminrusimha S, Keszler M. Persistent Pulmonary Hypertension of the Newborn. Neoreviews. 2015 Dec;16(12):e680-e692. doi: 10.1542/neo.16-12-e680.
- Buchiboyina A, Jasani B, Deshmukh M, Patole S. Strategies for managing transient tachypnoea of the newborn - a systematic review. J Matern Fetal Neonatal Med. 2017 Jul;30(13):1524-1532. doi: 10.1080/14767058.2016.1193143. Epub 2016 Oct 20.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Lung Diseases
- Infant, Newborn, Diseases
- Signs and Symptoms, Respiratory
- Infant, Premature, Diseases
- Respiratory Distress Syndrome, Newborn
- Respiratory Distress Syndrome
- Hypertension
- Hypertension, Pulmonary
- Tachypnea
- Transient Tachypnea of the Newborn
Other Study ID Numbers
- PRE-HIFREQ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transient Tachypnea of the Newborn
-
New York Hospital QueensCompleted
-
University of CologneCompletedTransient Tachypnoea of the NewbornGermany
-
Zekai Tahir Burak Women's Health Research and Education...UnknownTransient Tachypnea of NewbornTurkey
-
Benha UniversityCompletedTransient Tachypnea of Newborn and Fetal AcidosisEgypt
-
Makassed General HospitalCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedRespiratory Distress Syndrome | Transient Tachypnea of Newborn
-
University Hospital, Strasbourg, FranceUnknownTransient Tachypnoea of the NewbornFrance
-
Ain Shams UniversityUnknownCesarean Delivery Affecting Fetus | Transient Tachypnea NewbornEgypt
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedRespiratory Distress Syndrome | Intrauterine Growth Retardation | Transient Tachypnea of NewbornTurkey
-
The Hospital for Sick ChildrenCompleted
Clinical Trials on modified Silverman scale
-
Pinar YasarCompletedStroke | Urinary Incontinence | Motor Skills DisordersTurkey
-
Mansoura University HospitalCompletedHypertension | Intra Cerebral HemorrhageEgypt
-
Diskapi Yildirim Beyazit Education and Research...Recruiting
-
Recep Tayyip Erdogan University Training and Research...CompletedChild, Only | Behavior | Anxiety, DentalTurkey
-
Nanco van der MaasUniversity Hospital, Basel, Switzerland; Physiotherapie Langmatten Binningen... and other collaboratorsCompletedMultiple SclerosisSwitzerland
-
The University of Texas Medical Branch, GalvestonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
University of British ColumbiaVancouver General HospitalCompleted
-
Fondazione Don Carlo Gnocchi OnlusUnknown
-
Ankara UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting